NDC 15631-0650

PETROSELINUM SATIVUM

Petroselinum Sativum

PETROSELINUM SATIVUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Petroselinum Crispum.

Product ID15631-0650_084303f1-86e1-4953-99dd-0a028ed82037
NDC15631-0650
Product TypeHuman Otc Drug
Proprietary NamePETROSELINUM SATIVUM
Generic NamePetroselinum Sativum
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-26
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePETROSELINUM CRISPUM
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0650-6

1000 TABLET in 1 CONTAINER (15631-0650-6)
Marketing Start Date2015-12-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0650-1 [15631065001]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-6 [15631065006]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-0 [15631065000]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-5 [15631065005]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-3 [15631065003]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-4 [15631065004]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-7 [15631065007]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

NDC 15631-0650-2 [15631065002]

PETROSELINUM SATIVUM TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-26
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
PETROSELINUM CRISPUM1 [hp_X]/1

OpenFDA Data

SPL SET ID:0bd8a805-c0b0-4974-8efe-aecb2801e7ce
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "PETROSELINUM SATIVUM" or generic name "Petroselinum Sativum"

    NDCBrand NameGeneric Name
    0220-3980Petroselinum sativumPETROSELINUM CRISPUM
    15631-0333PETROSELINUM SATIVUMPETROSELINUM SATIVUM
    15631-0650PETROSELINUM SATIVUMPETROSELINUM SATIVUM
    37662-2331Petroselinum SativumPetroselinum Sativum
    37662-2332Petroselinum SativumPetroselinum Sativum
    37662-2333Petroselinum SativumPetroselinum Sativum
    37662-2334Petroselinum SativumPetroselinum Sativum
    37662-2335Petroselinum SativumPetroselinum Sativum
    37662-2336Petroselinum SativumPetroselinum Sativum
    37662-2337Petroselinum SativumPetroselinum Sativum
    37662-2338Petroselinum SativumPetroselinum Sativum
    71919-529Petroselinum sativumPETROSELINUM CRISPUM

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.